• 

  XIV Fórum Nacional de Políticas de Saúde no Brasil – Doenças Raras

  News
• 
• 

XIV Fórum Nacional de Políticas de Saúde no Brasil – Doenças Raras

By Zalika Famaceutica|2023-09-26T09:34:51-03:00September 26, 2023|News|

• 

  Protegendo Nossos Jovens: Prevenção de Doenças Raras na Comunidade Judaica

  News

Protegendo Nossos Jovens: Prevenção de Doenças Raras na Comunidade Judaica

By Zalika Famaceutica|2023-09-14T16:13:28-03:00September 14, 2023|News|

• 

  Nuvaxovid COVID-19 Vaccine Receives Full Authorization in Europe

  News

Nuvaxovid COVID-19 Vaccine Receives Full Authorization in Europe

By Zalika Famaceutica|2023-07-08T18:09:22-03:00July 7, 2023|News|

• 

  8th Edition – 10 years –The scenario of Rare Diseases in Brazil 2023

  News

8th Edition – 10 years –The scenario of Rare Diseases in Brazil 2023

By Zalika Famaceutica|2023-06-19T15:54:04-03:00June 19, 2023|News|

• 

  6CCV

  News

6CCV

By Zalika Famaceutica|2023-06-12T16:15:29-03:00June 12, 2023|News|

• 

  Novo remédio mais caro do mundo: para que serve e por que custa tão caro o Hemgenix

  News

Novo remédio mais caro do mundo: para que serve e por que custa tão caro o Hemgenix

By Zalika Famaceutica|2022-12-21T11:25:10-03:00December 21, 2022|News|

• 

  SUS fornecerá Zolgensma, um dos remédios mais caros do mundo, para crianças com AME

  News

SUS fornecerá Zolgensma, um dos remédios mais caros do mundo, para crianças com AME

By Zalika Famaceutica|2022-12-08T09:18:45-03:00December 3, 2022|News|

• 

  WORLD HEALTH ORGANIZATION UPDATES EMERGENCY USE LISTING FOR NOVAVAX NUVAXOVID COVID-19 VACCINE AS A PRIMARY SERIES IN ADOLESCENTS AND AS A BOOSTER IN ADULTS

  News

WORLD HEALTH ORGANIZATION UPDATES EMERGENCY USE LISTING FOR NOVAVAX NUVAXOVID COVID-19 VACCINE AS A PRIMARY SERIES IN ADOLESCENTS AND AS A BOOSTER IN ADULTS

By Zalika Famaceutica|2022-11-30T11:32:28-03:00November 29, 2022|News|

• 

  FDA APPROVES TREMELIMUMAB PLUS DURVALUMAB FOR ADULT PATIENTS WITH UNRESECTABLE HCC

  News

FDA APPROVES TREMELIMUMAB PLUS DURVALUMAB FOR ADULT PATIENTS WITH UNRESECTABLE HCC

By Zalika Famaceutica|2022-10-25T18:27:26-03:00October 25, 2022|News|

• 

  EXECUTIVES FROM ZALIKA FAMARCÊUTICA DURING A MEETING WITH THE EXECUTIVE SECRETARY OF THE MINISTRY OF HEALTH, BRUNO DALCOLMO IN BRASÍLIA

  News

EXECUTIVES FROM ZALIKA FAMARCÊUTICA DURING A MEETING WITH THE EXECUTIVE SECRETARY OF THE MINISTRY OF HEALTH, BRUNO DALCOLMO IN BRASÍLIA

By Zalika Famaceutica|2022-10-25T18:14:53-03:00September 23, 2022|News|